Borealis Foods Inc. (BRLS) is an integrated food-science and manufacturing company headquartered in Oakville, Ontario, producing high-protein, plant-based instant ramen under the Chef Woo, Chef Ramsay, Ramen Express and Woodles brands at its Palmetto Gourmet Foods plant in Saluda, South Carolina. Shares traded at $0.8936 on Wednesday morning, a decline of 9.18% from the previous session's close of $0.9797, confirming a decisively negative move. The stock opened at $0.93, slid as far as $0.702, then rebounded toward $0.95 before fading again. No fresh company announcement was issued on Wednesday itself; the operative catalyst is the company's Nov. 16 notification that its September-quarter 10-Q cannot be filed on time because the June-quarter 10-Q remains outstanding while accounting for a previously disclosed Conversion Agreement is reviewed.
The late-filing notification disclosed that the June 30, 2026 Form 10-Q is still unfinished, which in turn prevents completion of the September 30 report. Management said it expects to file both within the five-calendar-day extension permitted under Rule 12b-25, with the June report filed immediately before the September one. For a company with a market capitalization of roughly $19 million and stockholders' equity that was negative at the last reported balance sheet date, a widening gap between operating reality and public disclosure is material. The preliminary numbers offered alongside the notice were constructive — September-quarter net revenue of about $9.45 million, up 33% year over year, with operating loss narrowing to roughly $0.25 million from $1.93 million — but investors focused on the fact that these figures remain unaudited and unfileable.
Borealis received a Nasdaq notice in late August indicating non-compliance with Listing Rule 5250(c)(1) after missing the June 10-Q. The company had until Oct. 26 to submit a compliance plan, and Nasdaq may allow up to Feb. 16, 2027 to regain compliance. The stock's slide back below $1.00 also matters: the shares have spent much of 2026 near or under that threshold, and a sustained sub-$1.00 bid raises the separate minimum-bid-price question. Wednesday's move extended a week-to-date decline of roughly 17%.
An early-November filing disclosed that the audit committee operated with two members for 32 days, a technical breach of Nasdaq's three-member requirement, remedied by a new appointment on Oct. 29. The same filing revealed that a $17 million term loan and $3 million convertible note were assigned to a sitting director's mother, converting those obligations into related-party transactions, and that a director resigned. None of this is new on Wednesday, but it reinforces the perception of weak financial reporting controls that the delayed filings already convey.
Volume was elevated relative to recent activity — roughly 5,000 shares changed hands by late morning against a 20-session average of about 2,800 — yet remained trivial in dollar terms, which amplifies percentage moves. The intraday range of $0.70 to $0.95, a spread of more than 30%, is characteristic of a thinly traded micro-cap rather than an institutional repricing. The selling was idiosyncratic: no packaged-food peer or consumer-staples benchmark moved anywhere near this magnitude, and the broader market was not the story. Technically, the stock broke back below both $1.00 and its recent $0.94–$1.15 trading band, leaving it down more than 45% year to date and far beneath its 52-week high of $3.48.
The score runs from 0 — no meaningful news and a routine move — to 100, meaning transformative news combined with an extreme, rare price swing. This event lands at 26 out of 100. The verified news is moderate: a late-filing notification and a lingering listing-compliance issue are material for a company this small, but they are procedural rather than operational, and preliminary third-quarter revenue growth was actually positive. The price move was only modestly unusual: at 9.18%, it was roughly 1.8 times the stock's typical daily move of about 5.2% over the last 60 sessions, and moves of similar or greater size occurred ten times in that window, including a 113% single-session surge in August. A routine swing for this name plus moderate news produces a low score.
The near-term focus is the five-day filing window. If both quarterly reports are filed as expected, some of the disclosure uncertainty lifts; another delay would sharpen delisting questions ahead of the February 2027 compliance deadline. Shareholders also face a vote on converting the $3 million note into common stock, a dilution event tied to mandated Nasdaq approval. Liquidity remains thin — cash stood at roughly $0.5 million on the last reported balance sheet — so financing terms and the trajectory of the $17 million term loan matter as much as the sales line. With no sell-side coverage or published consensus, price discovery depends heavily on filings and occasional press releases about retail and school-foodservice expansion. Risks include further reporting delays, potential Nasdaq action, dilution and the possibility that preliminary results differ from final audited figures.
Tickeron's Trending AI Robots page curates the strongest-performing automated strategies across current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only a select group earns a place in this featured section. Bots differ by strategy logic, holding timeframe, performance metrics and the symbols they trade, so the lineup shifts as conditions change. Reviewing the current leaders can help traders see which approaches are working right now — explore the page to compare live performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for BRLS moved out of oversold territory on October 13, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 23 of the 24 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRLS advanced for three days, in 79 of 133 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
BRLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRLS as a result. In 53 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for BRLS turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 64 similar instances when the indicator turned negative. In 34 of the 64 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRLS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for BRLS entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.508) is normal, around the industry mean (6.914). P/E Ratio (-1.058) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.939) is also within normal values, averaging (5.003).
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. BRLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified